Phosphoinositide 3-kinase and INPP4B in human breast cancer.
about
Pharmacodynamic Biomarker Development for PI3K Pathway TherapeuticsThe PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers.Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinomaTransformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potentialDiscovery and development of small molecule SHIP phosphatase modulators.The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedsidePhosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival.The PIKfyve-ArPIKfyve-Sac3 triad in human breast cancer: Functional link between elevated Sac3 phosphatase and enhanced proliferation of triple negative cell lines.Inositol lipid phosphatases in membrane trafficking and human disease.INPP4B-mediated DNA repair pathway confers resistance to chemotherapy in acute myeloid leukemia.Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells.Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.The genomic signature of breast cancer preventionMolecular subtyping of mammary-like adenocarcinoma of the vulva shows molecular similarity to breast carcinomas.miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer.Efficacy of buparlisib in treating breast cancer.
P2860
Q26766292-D1A9B993-206F-44FE-BF4B-1448E276FDA7Q33937368-EC2C5A10-73F2-419D-BF06-DB8F3DA226A5Q34050917-DD0BBB48-EFE0-4359-823F-2077AADEDCCCQ34391423-DA66C33A-CAB8-459C-8E55-3C2464CA0FF6Q35000248-CA044DBF-686D-4EA2-A4FD-0CFAA4253E4FQ35058356-B077E5F8-69BC-4BAA-9835-C7688BB6979BQ35582498-DB5F32E0-9592-4E33-BFA7-AAA6351FDFC1Q36918028-423E6FB1-9D98-43DE-BB0A-8C994C1C9166Q37543548-A49722A8-11F9-43C3-9D60-5433CC5B4654Q38223317-A153E450-2332-4377-922D-8037DB04D1E2Q38736981-2286CF22-98EA-4ECC-A560-BB088CB57884Q38779492-8540A13E-A8DD-4F4E-84FA-FC8B9FE7F786Q39034710-5F55896C-4301-4C90-B852-0AC3D09253CBQ40656600-AB447CFB-2AB8-44E4-83DC-13D29BF8DA5BQ42131091-608AD57F-AC56-4EC1-8CC6-1214D9D47D87Q42508624-1A2D6FF0-C764-4665-A363-43D1A919CE0FQ48209624-EF65C9EC-4FF9-41B5-BADB-B53B2FA2AFE8Q49711965-1A23E458-61C4-4E82-9A00-ED654CA79A7B
P2860
Phosphoinositide 3-kinase and INPP4B in human breast cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Phosphoinositide 3-kinase and INPP4B in human breast cancer.
@en
type
label
Phosphoinositide 3-kinase and INPP4B in human breast cancer.
@en
prefLabel
Phosphoinositide 3-kinase and INPP4B in human breast cancer.
@en
P2860
P356
P1476
Phosphoinositide 3-kinase and INPP4B in human breast cancer.
@en
P2093
Micka C Bertucci
P2860
P356
10.1111/NYAS.12036
P407
P577
2013-03-01T00:00:00Z